Noguiez-Hellin P - Search Results

1

Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors.

Herath NI, Berthault N, Thierry S, Jdey W, Lienafa MC, Bono F, Noguiez-Hellin P, Sun JS, Dutreix M. Herath NI, et al. Among authors: noguiez hellin p. Front Oncol. 2019 Nov 12;9:1097. doi: 10.3389/fonc.2019.01097. eCollection 2019. Front Oncol. 2019. PMID: 31781480 Free PMC article.

2

Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors.

Jdey W, Thierry S, Russo C, Devun F, Al Abo M, Noguiez-Hellin P, Sun JS, Barillot E, Zinovyev A, Kuperstein I, Pommier Y, Dutreix M. Jdey W, et al. Among authors: noguiez hellin p. Clin Cancer Res. 2017 Feb 15;23(4):1001-1011. doi: 10.1158/1078-0432.CCR-16-1193. Epub 2016 Aug 24. Clin Cancer Res. 2017. PMID: 27559053 Free PMC article.

3

The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood.

Thierry S, Jdey W, Alculumbre S, Soumelis V, Noguiez-Hellin P, Dutreix M. Thierry S, et al. Among authors: noguiez hellin p. Mol Cancer Ther. 2017 Dec;16(12):2817-2827. doi: 10.1158/1535-7163.MCT-17-0405. Epub 2017 Sep 25. Mol Cancer Ther. 2017. PMID: 28947503

4

Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line.

Lemoine FM, Mesel-Lemoine M, Cherai M, Gallot G, Vié H, Leclercq V, Trébèden-Negre H, Mammès O, Boyer O, Noguiez-Hellin P, Klatzmann D. Lemoine FM, et al. Among authors: noguiez hellin p. J Gene Med. 2004 Apr;6(4):374-86. doi: 10.1002/jgm.538. J Gene Med. 2004. PMID: 15079812

5

Plasmoviruses: nonviral/viral vectors for gene therapy.

Noguiez-Hellin P, Meur MR, Salzmann JL, Klatzmann D. Noguiez-Hellin P, et al. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4175-80. doi: 10.1073/pnas.93.9.4175. Proc Natl Acad Sci U S A. 1996. PMID: 8633036 Free PMC article.

6

[Generation of a trans-complementable defective recombinant provirus and loading a transgene].

Noguiez-Hellin P, Robert-Le Meur M, Laune S, Salzmann JL, Klatzmann D. Noguiez-Hellin P, et al. C R Acad Sci III. 1996 Jan;319(1):45-50. C R Acad Sci III. 1996. PMID: 8673619 French.

7

Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency.

Yates F, Malassis-Séris M, Stockholm D, Bouneaud C, Larousserie F, Noguiez-Hellin P, Danos O, Kohn DB, Fischer A, de Villartay JP, Cavazzana-Calvo M. Yates F, et al. Among authors: noguiez hellin p. Blood. 2002 Dec 1;100(12):3942-9. doi: 10.1182/blood-2002-03-0782. Epub 2002 Aug 22. Blood. 2002. PMID: 12393742 Free article.

8

Plasmovirus: replication cycle of a novel nonviral/viral vector for gene transfer.

Morozov VA, Noguiez-Hellin P, Laune S, Tamboise E, Salzmann JL, Klatzmann D. Morozov VA, et al. Among authors: noguiez hellin p. Cancer Gene Ther. 1997 Sep-Oct;4(5):286-93. Cancer Gene Ther. 1997. PMID: 9345600

9

Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application.

Merten OW, Charrier S, Laroudie N, Fauchille S, Dugué C, Jenny C, Audit M, Zanta-Boussif MA, Chautard H, Radrizzani M, Vallanti G, Naldini L, Noguiez-Hellin P, Galy A. Merten OW, et al. Among authors: noguiez hellin p. Hum Gene Ther. 2011 Mar;22(3):343-56. doi: 10.1089/hum.2010.060. Epub 2011 Mar 7. Hum Gene Ther. 2011. PMID: 21043787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters